Susanna Dunachie

Susanna Dunachie publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Susanna Dunachie sits on this spectrum.

Susanna Dunachie D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Susanna Dunachie sits on this spectrum.

Overview

Best Publications

• Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

  M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  4904
  Citations

• SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

  Unknown

  1679
  Citations

• Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

  M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  1285
  Citations

• Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

  Y Peng;A J Mentzer;G Liu;G Liu;X Yao

  1277
  Citations

• Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

  Unknown

  1232
  Citations

• Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

  D Zhou;W Dejnirattisai;P Supasa;C Liu

  1044
  Citations

• SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

  Unknown

  1015
  Citations

• COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

  Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  743
  Citations

• Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

  Samuel J McConkey;William H H Reece;Vasee S Moorthy;Daniel Webster

  735
  Citations

• SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

  V J Hall;S Foulkes;A Charlett;A Atti

  690
  Citations

• Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

  C Liu;H M Ginn;W Dejnirattisai;P Supasa

  686
  Citations

• T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

  K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  609
  Citations

• The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017

  J D Stanaway;A Parisi;K Sarkar;B F Blacker

  600
  Citations

• Antibody evasion by the P.1 strain of SARS-CoV-2.

  W Dejnirattisai;D Zhou;P Supasa;C Liu

  576
  Citations

• A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

  Unknown

  488
  Citations

• Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

  P Supasa;D Zhou;W Dejnirattisai;C Liu

  487
  Citations

• Upregulation of TGF-β, FOXP3, and CD4+CD25+ Regulatory T Cells Correlates with More Rapid Parasite Growth in Human Malaria Infection

  Michael Walther;Jon Eric Tongren;Laura Andrews;Daniel Korbel

  481
  Citations

• Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

  M Ainsworth;M Andersson;M Andersson;K Auckland;J K Baillie

  367
  Citations

• Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

  Daniel P. Webster;Susanna Dunachie;Jenni M. Vuola;Tamara Berthoud

  330
  Citations

• Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.

  R P Payne;S Longet;J A Austin;D T Skelly

  321
  Citations

• Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

  Barrett;S Belij-Rammerstorfer;C Dold;K J Ewer

  318
  Citations

• Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

  Unknown

  277
  Citations

• A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

  S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  238
  Citations

• Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

  J Frater;K J Ewer;A Ogbe;M Pace

  232
  Citations

• Calculation of Liver-to-Blood Inocula, Parasite Growth Rates, and Preerythrocytic Vaccine Efficacy, from Serial Quantitative Polymerase Chain Reaction Studies of Volunteers Challenged with Malaria Sporozoites

  Philip Bejon;Laura Andrews;Rikke F. Andersen;Susanna Dunachie

  219
  Citations

• Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

  Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

  28
  Citations